William Lewis, Director, Chair and CEO, on June 25, 2026, sold 21,398 shares in Insmed (INSM) for $2,210,763. Following the Form 4 filing with the SEC, Lewis has control over a total of 492,841 common shares of the company, with 258,917 shares held directly and 233,924 controlled indirectly.
SEC Filing:
Robert P. Farrell, President, Communication and Computing, on June 23, 2026, sold 2,920 shares in TTM Technologies (TTMI) for $612,598. Following the Form 4 filing with the SEC, Farrell has control over a total of 16,486 common shares of the company, with 16,486 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1116942/000119312526283125/xslF345X05/ownership.xml
Daniel L. Boehle, Executive Vice President and CFO, on June 23, 2026, sold 6,341 shares in TTM Technologies (TTMI) for $1,330,307. Following the Form 4 filing with the SEC, Boehle has control over a total of 72,922 common shares of the company, with 72,922 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1116942/000119312526283127/xslF345X05/ownership.xml
Dale Martin Knecht, Senior Vice President, Information Technology, on June 23, 2026, sold 6,754 shares in TTM Technologies (TTMI) for $1,416,952. Following the Form 4 filing with the SEC, Knecht has control over a total of 68,350 common shares of the company, with 68,350 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1116942/000119312526283121/xslF345X05/ownership.xml